Evidence map›Paper›PMID 24349631›Full record

ReviewGenes & cancer2013

Mixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer.

Ajay Rana, Basabi Rana, Rajakishore Mishra, Gautam Sondarva, Velusamy Rangasamy, Subhasis Das, Navin Viswakarma, Anumantha Kanthasamy

Open access · bronzeAbstract readReview
In one paragraph

Review in Genes & cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ajay RanaDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA ; Hines Veterans Affairs Medical Center, Hines, IL, USA.
Basabi RanaHines Veterans Affairs Medical Center, Hines, IL, USA ; Division of Gastroenterology, Department of Medicine, Loyola University Chicago, Maywood, IL, USA.
Rajakishore MishraDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA ; Centre for Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ranchi, India.
Gautam SondarvaDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA.
Velusamy RangasamyDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA ; Department of Veterinary Parasitology, Veterinary College and Research Institute, Namakkal, India.
Subhasis DasDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA.
Navin ViswakarmaDepartment of Molecular Pharmacology & Therapeutics, Loyola University Chicago, Maywood, IL, USA.
Anumantha KanthasamyDepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Loyola University Chicago · USIowa State University · USVeterans Health Administration · US

Funding

MMT, DOPAMINERGIC DEGENERATION, AND AGINGR01ES010586 · NIEHS · IOWA STATE UNIVERSITY · PI KANTHASAMY, ANUMANTHA GOUNDER · 2000 to 2015
$4.6M
Role of Mixed Lineage Kinase 3/SPRK in Stress SignalingR01GM055835 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI RANA, AJAY NMN · 1999 to 2010
$1.8M
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast CancerR01CA176846 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RANA, AJAY NMN · 2013 to 2017
$1.6M
Oxidative Stress Induced Compensatory Protective Mechanisms in PDR01NS074443 · NINDS · IOWA STATE UNIVERSITY · PI KANTHASAMY, ANUMANTHA GOUNDER · 2011 to 2015
$1.6M
Role of MLK3 in beta catenin signaling in prostate cancerR21CA121221 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI RANA, BASABI · 2007 to 2008
$300k
Molecular Mechanisms of Gastrin Mediated Pathways in Gastric Cancer CellsI01BX000571 · VA · EDWARD HINES JR VA HOSPITAL · PI RANA, BASABI · 2011 to 2014
–
Regulation of Breast Cancer Growth by MLK-3I01BX000312 · VA · EDWARD HINES JR VA HOSPITAL · PI RANA, AJAY NMN · 2011 to 2013
–
BLRD VA I01 BX000312BLRD VA I01 BX000571NCI NIH HHS R01 CA176846NCI NIH HHS R21 CA121221NIEHS NIH HHS R01 ES010586NIGMS NIH HHS R01 GM055835NINDS NIH HHS R01 NS074443
6 · The paper itself

Abstract

Mixed lineage kinases (MLKs) are members of the mitogen-activated protein kinase kinase kinase (MAP3K) family and are reported to activate MAP kinase pathways. There have been at least 9 members of the MLK family identified to date, although the physiological functions of all the family members are yet unknown. However, MLKs in general have been implicated in neurodegenerative diseases, including Parkinson and Alzheimer diseases. Recent reports suggest that some of the MLK members could play a role in cancer via modulating cell migration, invasion, cell cycle, and apoptosis. This review article will first describe the biology of MLK members and then discuss the current progress that relates to their functions in cancer.

Indexed as

cancerJNKMAPKsMLKsphosphorylation

Identifiers

PMID24349631
PMCPMC3863337
OpenAlexW2098301815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.